Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFDA Advisory Committee Hears Presentations and Public Comment on EXALGO Extended-Release Tablets
Covidien, 09/28/09
Covidien, a leading global provider of healthcare products, announced that it presented information to members of a U.S. Food and Drug Administration Advisory Committee on the New Drug Application and proposed Risk Evaluation and Mitigation Strategy program for EXALGOTM tablets, an opioid formulation. At a meeting held in Gaithersburg, Md., committee members also heard public comments about the analgesic. Covidien will now await FDA's decision on EXALGO approval.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Sanofi Pasteur obtains license from Syntiron to develop & commercialize vaccine to prevent Staphylococcus infections
Sanofi-aventis, 12/17/09
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Sponsor
Article Search
Sponsor
Sponsor